Skip to main content
. 2020 Nov 6;99(45):e23157. doi: 10.1097/MD.0000000000023157

Table 1.

Patient demographics in this study.

Nonfunctioning tumor (N = 969) GH-secreting tumor (N = 317) P
Age, yr 46.68 ± 13.87 44.06 ± 12.09 .001
Sex (male/female) 362/607 147/170 .004
Height, cm 164.45 ± 8.34 168.27 ± 10.11 <.001
Weight, kg 65.77 ± 12.85 71.62 ± 14.15 <.001
BMI 24.23 ± 3.82 25.14 ± 3.48 <.001
ASA (1/2/3/4) 284/558/123/4 0/261/55/1 <.001
Hypertension 198 (20.4%) 102 (32.2%) <.001
Diabetes mellitus 79 (8.2%) 74 (23.3%) <.001
Coronary artery disease 23 (2.4%) 4 (1.3%) .231
Duration of surgery, min 181.19 ± 78.34 206.10 ± 94.64 .002
Duration of anesthesia, min 273.80 ± 89.41 291.95 ± 100.76 .002
Tumor size (> 1 cm) 871 (89.9%) 275 (86.8%) .120
Sinus invasion 372 (38.3%) 128 (40.4%) .528
Bleeding, mL 238.65 ± 267.69 265.87 ± 249.16 .110